Contact Us

Companion Diagnostics

Expression Pathology is collaborating with pharmaceutical companies. We offer our menu of Liquid Tissue®-SRM Assays for preclinical and clinical development with the aim of advancing assays that can improve patient stratification.

We also engage in biomarker discovery projects where our technology is used for global proteomic profiling. Comparing tissue samples from responders and non-responders, for example, can help identify differentially expressing candidate biomarkers, which can subsequently be measured using Liquid Tissue®-SRM based methods.

Studies performed at Expression Pathology adhere to the Good Laboratory Practice regulations set forth by the FDA (21 CFR Part 58)